Abstract <p>Triazole-thiazole hybrids represent highly privileged scaffolds in medicinal chemistry, characterized by exceptional structural versatility and a broad spectrum of pharmacological profiles, including anticancer, antimicrobial, antidiabetic, and anti-inflammatory activities. This review provides a critical overview of recent advancements in the synthesis, structure–activity relationships (SAR), and therapeutic applications of these dual-heterocyclic frameworks. We highlight strategic methodologies for integrating triazole and thiazole cores with complementary pharmacophores to enhance potency, optimize pharmacokinetic profiles, and circumvent multi-drug resistance. Furthermore, current optimization bottlenecks and emerging computational paradigms are systematically evaluated. Ultimately, this survey delineates key design principles for leveraging the modularity of triazole-thiazole scaffolds in the development of next-generation, multi-target directed ligands (MTDLs) against complex etiologies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Beyond Single Targets: A Review of Triazole-Thiazole Hybrids in Modern Drug Design

  • Prashant J. Burange,
  • Pinkal H. Patel,
  • Tejaswini P. Masne

摘要

Abstract

Triazole-thiazole hybrids represent highly privileged scaffolds in medicinal chemistry, characterized by exceptional structural versatility and a broad spectrum of pharmacological profiles, including anticancer, antimicrobial, antidiabetic, and anti-inflammatory activities. This review provides a critical overview of recent advancements in the synthesis, structure–activity relationships (SAR), and therapeutic applications of these dual-heterocyclic frameworks. We highlight strategic methodologies for integrating triazole and thiazole cores with complementary pharmacophores to enhance potency, optimize pharmacokinetic profiles, and circumvent multi-drug resistance. Furthermore, current optimization bottlenecks and emerging computational paradigms are systematically evaluated. Ultimately, this survey delineates key design principles for leveraging the modularity of triazole-thiazole scaffolds in the development of next-generation, multi-target directed ligands (MTDLs) against complex etiologies.